newsfilter
← Latest News
PR Newswire·

Canton Strategic Holdings, Inc. Announces Sale of Gravitas Life Sciences, LLC

  • Canton Strategic Holdings, Inc. (NASDAQ: CNTN) announced the sale of its biotech arm, Gravitas Life Sciences, LLC, to Gravitas Collective Corp.
  • The transaction was unanimously approved by the Board of Directors and closed on July 17, 2026.
  • This sale aligns with the company's strategic transition to an operating entity focused on digitizing financial markets via the Canton Network.
  • The move builds on recent operational progress, including the launch of its locking service in June 2026.
  • Canton Strategic Holdings is the first publicly traded company to leverage Canton Coin to support the Canton Network's institutional blockchain adoption efforts.
  • Digital Asset (Switzerland) GmbH holds the registered trademark for "Canton" but is not affiliated with or responsible for the company's operations.